ロード中...
Updating the landscape of direct-to-consumer pharmacogenomic testing
Pharmacogenomics has identified important drug–gene interactions that affect the safety and efficacy of medications. Direct-to-consumer genetic testing, when first introduced, included some pharmacogenomic-related genes. The current landscape of pharmacogenomic direct-to-consumer testing is reviewed...
保存先:
| 出版年: | Pharmgenomics Pers Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572950/ https://ncbi.nlm.nih.gov/pubmed/28860839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S140461 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|